Clene, Inc. (CLNN)
4.105
-0.18
(-4.09%)
USD |
NASDAQ |
Sep 01, 16:00
4.12
+0.02
(+0.37%)
After-Hours: 18:59
Clene Total Long Term Debt (Quarterly) : 21.53M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 21.53M |
| March 31, 2026 | 21.22M |
| December 31, 2025 | 20.86M |
| September 30, 2025 | 20.53M |
| June 30, 2025 | 19.83M |
| March 31, 2025 | 19.96M |
| December 31, 2024 | 19.92M |
| September 30, 2024 | 22.15M |
| June 30, 2024 | 32.00M |
| March 31, 2024 | 31.84M |
| December 31, 2023 | 31.58M |
| September 30, 2023 | 31.36M |
| June 30, 2023 | 31.14M |
| March 31, 2023 | 31.85M |
| December 31, 2022 | 31.34M |
| September 30, 2022 | 26.34M |
| June 30, 2022 | 26.30M |
| Date | Value |
|---|---|
| March 31, 2022 | 25.34M |
| December 31, 2021 | 23.70M |
| September 30, 2021 | 23.52M |
| June 30, 2021 | 16.73M |
| March 31, 2021 | 3.916M |
| December 31, 2020 | 4.129M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| NovelStem International Corp. | 1.620M |
| Brainstorm Cell Therapeutics, Inc. | 0.00 |
| Summit Therapeutics, Inc. | 16.83M |
| Kezar Life Sciences, Inc. | 0.00 |
| Protara Therapeutics, Inc. | 1.463M |